Condition
Locally Recurrent Oral Cavity Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Locally Recurrent Oral Cavity Squamous Cell Carcinoma clinical trials that are recruiting, in United States. By phase: Phase 2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Locally Recurrent Oral Cavity Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Proton or Photon Radiotherapy Added to Pembrolizumab Before Surgery for Advanced or Recurrent Oral Cavity Cancer | Phase 2 | Rochester, Minnesota | Recruiting | Aug 25, 2026 |
| Adding chemotherapy or chemo-immunotherapy to standard salvage surgery for advanced head and neck cancer | Phase 2 | Tucson, Arizona and 114 other locations | Recruiting | Sep 29, 2025 |
| Using cemiplimab and cetuximab before surgery for recurrent oral cavity cancer | Phase 2 | Houston, Texas | Recruiting | Jun 7, 2024 |
| Combining cabozantinib and nivolumab to treat advanced melanoma and head and neck cancer | Phase 2 | Phoenix, Arizona and 231 other locations | Recruiting | Nov 29, 2021 |
All recruiting trials (4)
-
Proton or Photon Radiotherapy Added to Pembrolizumab Before Surgery for Advanced or Recurrent Oral Cavity Cancer
This phase 2 trial tests whether adding proton SFRT or SBRT to pembrolizumab before surgery helps patients with advanced or recurrent oral cavity cancer.
-
Adding chemotherapy or chemo-immunotherapy to standard salvage surgery for advanced head and neck cancer
This trial tests whether giving chemotherapy alone or chemotherapy plus the immunotherapy cemiplimab before salvage surgery helps people with PD-L1–positive recurrent or persistent head and neck squamous cell carcinoma.
-
Using cemiplimab and cetuximab before surgery for recurrent oral cavity cancer
This study is testing if the drugs cemiplimab and cetuximab can help control recurrent oral cavity cancer before surgery to improve patient outcomes.
-
Combining cabozantinib and nivolumab to treat advanced melanoma and head and neck cancer
This study is testing a combination of two cancer drugs, cabozantinib and nivolumab, to see if they can help people with advanced melanoma or head and neck cancer while also looking at how to better match treatments to patients based on their tumor characteristics.
Related topics
Quick answers
How many Locally Recurrent Oral Cavity Squamous Cell Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.